Literature DB >> 7387146

Treatment of cellulitis with ceforanide.

D M Musher, V Fainstein, E J Young.   

Abstract

Thirty-five patients with cellulitis were treated with ceforanide, 1 g every 12 h, intramuscularly. A good clinical response was observed in 33 cases. Drug failure in the remaining two patients was thought to be due to the lack of surgical debridement. Drug concentrations well in excess of inhibitory levels for Streptococcus pyogenes were generally present throughout the treatment period; although this was not true of ceforanide concentrations relative to inhibitory levels for Staphylococcus aureus, the clinical response in patients with staphylococcal infection still appeared to be entirely satisfactory. Killing of S. pyogenes by 5, 50, and 500X the minimum inhibitory concentration of ceforanide proceeded at the same rate in vitro as did killing by 5, 50, and 500X the minimum inhibitory concentration of penicillin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387146      PMCID: PMC283767          DOI: 10.1128/AAC.17.2.254

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.

Authors:  R V Goering; C C Sanders; W Sanders
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

2.  Clinical and pharmacologic evaluation of cefazolin in children.

Authors:  L K Pickering; D M O'Connor; D Anderson; A C Bairan; R D Feigin; J D Cherry
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

3.  Surgical management of soft tissue infections.

Authors:  C R Baxter
Journal:  Surg Clin North Am       Date:  1972-12       Impact factor: 2.741

4.  In vitro activity of cefazolin against recent clinical bacterial isolates.

Authors:  L D Sabath; C Wilcox; C Garner; M Finland
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

5.  Ceforanide (BL-S786) in the treatment of community-acquired bacterial pneumonia.

Authors:  R J Wallace; R R Martin; S B Greenberg
Journal:  Infection       Date:  1979       Impact factor: 3.553

6.  Erysipelas and necrotizing fasciitis.

Authors:  H Hammar; L Wanger
Journal:  Br J Dermatol       Date:  1977-04       Impact factor: 9.302

7.  Low dose penicillin for gonococcal arthritis. A comparative therapy trial.

Authors:  D E Trentham; J W McCravey; A T Masi
Journal:  JAMA       Date:  1976-11-22       Impact factor: 56.272

8.  Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins.

Authors:  M Laverdiere; D Welter; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

9.  In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole.

Authors:  S Shadomy; G Wagner; M Carver
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

10.  Ceforanide: in vitro and clinical evaluation.

Authors:  K H Burch; D Pohlod; L D Saravolatz; T Madhavan; D Kiani; E L Quinn; R Del Busto; J Cardenas; E J Fisher
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

  10 in total
  5 in total

1.  Diagnosis of cellulitis in the immunocompromised host.

Authors:  C F Carey; L Dall
Journal:  Can J Infect Dis       Date:  1990

2.  Synthesis and Suzuki-Miyaura cross-coupling reactions of potassium Boc-protected aminomethyltrifluoroborate with aryl and hetaryl halides.

Authors:  Gary A Molander; Inji Shin
Journal:  Org Lett       Date:  2011-07-06       Impact factor: 6.005

Review 3.  Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D M Campoli-Richards; T E Lackner; J P Monk
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

4.  Suzuki-Miyaura cross-coupling reactions of potassium Boc-protected aminomethyltrifluoroborate with aryl and hetaryl mesylates.

Authors:  Gary A Molander; Inji Shin
Journal:  Org Lett       Date:  2012-05-31       Impact factor: 6.005

Review 5.  Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis.

Authors:  Michelle A Boettler; Benjamin H Kaffenberger; Catherine G Chung
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.